Low-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani Adults (opens ClinicalTrials.gov)
- Sponsor
- Asian Institute Of Medical Sciences
- Enrolment
- 60
- Started
- 2025-08-01
- Last update
- 2026-04-06
Conditions: Obesity, Weight Reduction, Cardiometabolic Risk Factors
Interventions: Locally available low-dose semaglutide (0.25 mg, 0.5 mg, 1 mg)